Author

S. Tong

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3 Bioengineering· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 4 Organism:rat· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Tamin· 2 shared K. Queen· 2 shared A. Burroughs· 1 shared A. L. Sangster· 1 shared A. Lim· 1 shared A. M. Assiri· 1 shared A. Price· 1 shared A. S. Laufer Halpin· 1 shared

Activity by Year

2021-2023 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Tamin

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Magnetic nanocomplexes coupled with an external magnetic field modulate macrophage phenotype: a non-invasive strategy for bone regeneration.

H. Suresh Kumar, Z. Yi, S. Tong, R. T. Annamalai

This study uses magnetic nanocomplexes with an external magnetic field to shift macrophage phenotype from proinflammatory to prohealing, promoting bone regeneration by modulating inflammation.

bioRxiv · Sep 2, 2023 · PreprintBioengineering

Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines

L. Wang, M. H. Kainulainen, N. Jiang, H. Di, G. Bonenfant, L. Mills, M. Currier, P. Shrivastava-Ranjan, B. M. Calderon, M. Sheth, B. R. Mann, J. Hossain, X. Lin, S. Lester, E. Pusch, , Davis

This study evaluates how well antibodies from mRNA vaccines neutralize SARS-CoV-2 variants, finding that Omicron shows the most escape but booster doses maintain moderate neutralizing activity.

bioRxiv · Nov 24, 2021Microbiology

Of Rats and Men, a Translational Model to Understand Vancomycin Pharmacokinetic/Toxicodynamic relationships

M. H. Scheetz, G. Pais, T. Lodise, S. Tong, J. Davis, J. N. O'Donnell, J. Liu, M. Neely, W. Prozialeck, P. Lamar, N. J. Rhodes, T. Holland

The paper links vancomycin toxicity data from a rat model to two human clinical studies, showing rats are more sensitive to kidney injury at therapeutic concentrations.

bioRxiv · Apr 22, 2021Pharmacology & Toxicology

One Health Investigation of SARS-CoV-2 Infection and Seropositivity among Pets in Households with Confirmed Human COVID-19 Cases - Utah and Wisconsin, 2020

G. W. Goryoka, C. M. Cossaboom, R. Gharpure, P. Dawson, C. Tansey, J. Rossow, V. Mrotz, J. Rooney, M. Torchetti, C. M. Loiacono, M. L. Killian, M. Jenkins-Moore, A. Lim, K. Poulsen, D. Christensen, , C. Barton Behravesh

This study investigates SARS-CoV-2 infection and seropositivity in pets from households with confirmed human COVID-19 cases, finding that 17% of pets had neutralizing antibodies and suggesting transmission from humans to pets.

bioRxiv · Apr 11, 2021Microbiology

Surface-aerosol stability and pathogenicity of diverse MERS-CoV strains from 2012 - 2018

N. van Doremalen, M. C. Letko, R. Fischer, T. Bushmaker, K. C. Yinda, J. Schulz, S. N. Seifert, N. J. Kim, M. G. Hemida, G. Kayali, W. B. Park, R. Perera, A. Tamin, N. J. Thornburg, S. Tong, , V. Munster

The paper examines the environmental stability, replication kinetics, and pathogenicity of diverse MERS-CoV strains and SARS-CoV-2, finding variation in stability and pathogenicity among isolates.

bioRxiv · Feb 11, 2021 · PreprintMicrobiology